# Comparison Between Infant Flow SiPAP and Noninvasive NAVA in the Neonatal Intensive Care Unit

> **NCT01588080** · NA · COMPLETED · sponsor: **Fraser Health** · enrollment: 21 (actual)

## Conditions studied

- Respiratory Distress Syndrome

## Interventions

- **DEVICE:** Neurally Adjusted Ventilatory Assist (NAVA)
- **DEVICE:** SiPAP - placebo

## Key facts

- **NCT ID:** NCT01588080
- **Lead sponsor:** Fraser Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2015-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01588080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01588080, "Comparison Between Infant Flow SiPAP and Noninvasive NAVA in the Neonatal Intensive Care Unit". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01588080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*